ATOH8 overexpression inhibits the tumor progression and monocyte chemotaxis in hepatocellular carcinoma.
ATOH8
Hepatocellular carcinoma
monocyte
tumor immune microenvironment
Journal
International journal of clinical and experimental pathology
ISSN: 1936-2625
Titre abrégé: Int J Clin Exp Pathol
Pays: United States
ID NLM: 101480565
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
06
2020
accepted:
24
09
2020
entrez:
9
11
2020
pubmed:
10
11
2020
medline:
10
11
2020
Statut:
epublish
Résumé
ATOH8 is reported to be associated with the progression of many tumors; however, there are remaining controversies. The aim of this study is to explore the role of ATOH8 in hepatocellular carcinoma (HCC) and its effect on monocyte chemotaxis. Bioinformatics analysis was performed based on the LIHC data in GEPIA and LinkedOmic. Fresh human liver cancer and adjacent nontumor tissue specimens were collected at the Shanghai Public Health Clinical Center. qRT-PCR was performed to determine the transcript level, and western blot analysis and ELISA were used to detect protein expression. CCK8, colony formation, wound-healing, Transwell migration and invasion assays were performed to examine cell proliferation, migration and invasion. An HCC xenograft mouse model was used to determine oncogenicity in vivo. Cell apoptosis and related markers were detected by flow cytometry. Additionally, chemotaxis was assessed by the Transwell migration assay. ATOH8 expression is downregulated in HCC tissue and hepatoma cell lines. High expression of ATOH8 predicts a favorable prognosis. Overexpression of ATOH8 in liver cancer cells inhibits proliferation, migration and invasion in vitro, and tumor progression in nude mice. Knockdown of ATOH8 promotes proliferation of Huh7 and EMT-related proteins. Overexpression of ATOH8 increases chemosensitivity to 5-FU, which is probably caused by inhibiting the phosphorylation of AKT (Ser473). Furthermore, overexpression of ATOH8 in Huh7 reduced MCP1 to inhibit chemotactic THP-1, and promoted antitumor inflammatory cytokine (TNF-α and IFN-γ) secretion in monocytes. In addition to the intrinsic oncosuppressive function of ATOH8 in the liver, ATOH8 may modulate the microenvironment to create an immune activation state. This may partly be attributed to ATOH8 inhibition of the monocyte recruitment via suppressing MCP1 expression so as to promote antitumor inflammatory cytokine secretion in monocytes.
Types de publication
Journal Article
Langues
eng
Pagination
2534-2543Informations de copyright
IJCEP Copyright © 2020.
Déclaration de conflit d'intérêts
None.
Références
BMC Cancer. 2017 Dec 19;17(1):870
pubmed: 29258450
Oncotarget. 2016 May 3;7(18):26765-79
pubmed: 27049918
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
J Mol Evol. 2009 Jun;68(6):629-40
pubmed: 19449054
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604
pubmed: 31439937
Cell. 2019 Aug 22;178(5):1102-1114.e17
pubmed: 31442403
Gastroenterology. 2015 Oct;149(4):1068-81.e5
pubmed: 26099525
Gut. 2017 Jan;66(1):157-167
pubmed: 26452628
Gastroenterology. 2007 Jun;132(7):2557-76
pubmed: 17570226
Oncogene. 2008 Mar 13;27(12):1749-58
pubmed: 17891174
Bull Cancer. 2018 May;105(5):493-501
pubmed: 29576222
Oncol Rep. 2017 May;37(5):2955-2963
pubmed: 28393252
Nat Rev Cancer. 2007 Jun;7(6):415-28
pubmed: 17508028
Semin Liver Dis. 2005;25(2):181-200
pubmed: 15918147
Ann Hepatol. 2019 Mar - Apr;18(2):291-297
pubmed: 31047849
Mol Cancer. 2019 Aug 29;18(1):130
pubmed: 31464625
J Exp Clin Cancer Res. 2020 Jan 30;39(1):25
pubmed: 32000836
Nat Rev Cancer. 2004 Jul;4(7):540-50
pubmed: 15229479
Cell. 2019 Sep 5;178(6):1509-1525.e19
pubmed: 31491389
PLoS One. 2011;6(8):e23005
pubmed: 21857980
Cell. 2016 May 19;165(5):1092-1105
pubmed: 27133165
Cancer Microenviron. 2012 Aug;5(2):133-49
pubmed: 21948460
Nat Rev Immunol. 2017 Sep;17(9):559-572
pubmed: 28555670
Sci Rep. 2017 Mar 31;7:45846
pubmed: 28361988
J Cell Physiol. 2013 Jul;228(7):1404-12
pubmed: 23065796
Nucleic Acids Res. 2018 Jan 4;46(D1):D956-D963
pubmed: 29136207